Shilpa Malik, MD
Otolaryngology · Stockton, CANPI 1316280142
Payments from drug & device makers
Across 31 payments — averaging $21.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$112
- GSK$77
- Medtronic$66
- Stryker$54
- Sanofi$53
- Aerin Medical Inc.$44
- plus $257 from 10 others
What the payments were for
- Food & beverage$662100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 6 | $112 |
| GSK | 3 | $77 |
| Medtronic(2 entities) | 3 | $66 |
| Stryker | 3 | $54 |
| Sanofi | 2 | $53 |
| Aerin Medical Inc. | 2 | $44 |
| Smith+Nephew | 3 | $44 |
| KARL Storz Endoscopy-america | 1 | $34 |
| Greer Laboratories, Inc. | 1 | $33 |
| Boehringer Ingelheim | 1 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| Kaleo, Inc. | 1 | $22 |
| ZOLL Respicardia, Inc. | 1 | $20 |
| Merck | 1 | $16 |
| Inspire Medical Systems, Inc. | 1 | $15 |
| Acclarent, Inc | 1 | $11 |
How this compares
$662 in reported general payments places this provider in the 40th percentile of 1,021 otolaryngology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 106 | $5,507 |
| Dexamethasone Sodium Phosphate | 113 | $5,420 |
| Fluticasone Propionate | 135 | $3,029 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 21 | $2,772 |
| Ipratropium Bromide | 50 | $2,350 |
| Montelukast Sodium | 58 | $985 |
| Ofloxacin | 29 | $884 |
| Famotidine | 70 | $810 |
| Pantoprazole Sodium | 72 | $610 |
| Clotrimazole | 12 | $524 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 39 | $452 |
| Clobetasol Propionate | 24 | $289 |
| Methylprednisolone | 53 | $260 |
| Prednisone | 19 | $99 |
| Cephalexin | 13 | $37 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Stockton
- Randall OwRoseville$4.3M
- Amir MoradiVista$2.6M
- Brian WeeksSan Diego$1.6M
- Charles LimbSan Francisco$1.5M
- Andrew BerosSan Diego$688K
- Paul SchalchChula Vista$573K
- Steven DavisTorrance$544K
- Arnaud BewleySacramento$541K
- Keith BlackwellLos Angeles$349K
- Kalpna DurairajSun Valley$348K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.